Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) rose 1% on Wednesday. The company traded as high as $1.07 and last traded at $1.05. 370,812 shares traded hands during mid-day trading, an increase of 453% from the average session volume of 67,097 shares. The stock had previously closed at $1.04.
Cardiol Therapeutics Stock Up 1.0%
The company’s 50 day moving average is $1.55 and its 200 day moving average is $1.29.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a Canadian clinical-stage biotechnology company focused on developing anti-inflammatory therapies for diseases of the heart and related conditions. The company’s research is centered on the therapeutic potential of cannabidiol and other compounds that may help reduce inflammation and fibrosis, or scarring, in cardiovascular tissues.
Its lead investigational product, CardiolRx, is an oral pharmaceutical formulation of cannabidiol that does not contain the intoxicating cannabinoid THC.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
